<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02642445</url>
  </required_header>
  <id_info>
    <org_study_id>HenanICE201502</org_study_id>
    <nct_id>NCT02642445</nct_id>
  </id_info>
  <brief_title>Renal Sympathetic Denervation From The Adventitia on Hypertension</brief_title>
  <acronym>RSDAH</acronym>
  <official_title>Efficacy and Safety of Renal Sympathetic Denervation From The Adventitia on Hypertension in Patients With Primary Aldosteronism</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Henan Institute of Cardiovascular Epidemiology</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Henan Institute of Cardiovascular Epidemiology</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Renal sympathetic denervation from the intima of renal arteries has become an important
      method for the treatment of resistant hypertension, but renal sympathetic nerve are mainly
      located in the adventitia, and there is no report about renal sympathetic denervation from
      the renal adventitia. Primary aldosteronism is an important factor of secondary hypertension,
      tumor aldosterone in unilateral adrenal can increase the concentration of plasma aldosterone,
      in some patients blood pressure control is still not desirable after resection of tumor
      aldosterone. This study intends to conduct renal sympathetic denervation ablation from the
      adventitia to observe its efficacy and safety on blood pressure of patients with primary
      aldosterone.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>December 2016</start_date>
  <completion_date type="Anticipated">December 2019</completion_date>
  <primary_completion_date type="Anticipated">December 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Change from Baseline Systolic Blood Pressure at 6 months,12 months, 18 months</measure>
    <time_frame>at 6 months,12 months,18 months</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Change from Baseline Renin at 6 months,12 months, 18 months</measure>
    <time_frame>at 6 months,12 months,18 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change from Baseline aldosterone at 6 months,12 months, 18 months</measure>
    <time_frame>at 6 months,12 months,18 months</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">60</enrollment>
  <condition>Primary Aldosteronism Due to Aldosterone Producing Adenoma</condition>
  <arm_group>
    <arm_group_label>Renal Sympathetic Denervation</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Renal sympathetic Denervation are conducted from the adventitia of renal artery</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control Group</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>Renal Sympathetic Denervation are not conducted in control group.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Renal Sympathetic Denervation</intervention_name>
    <description>We applied a ablation catheter for discrete radiofrequency ablations of 8 W or less and lasting up to 2 min each to obtain up to four-six ablations separated both longitudinally and rotationally from the adventitia</description>
    <arm_group_label>Renal Sympathetic Denervation</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. . Renal artery diameter ≥4 mm and Length ≥20 mm;

          2. . 18 years old ≤ age ≤ 70 years old;

          3. . Specific diagnosis of adrenal adenoma and primary aldosteronism before the patients
             are enrolled in the study;

          4. . Clinic systolic blood pressure≥160 mmHg and/or diastolic blood pressure≥100 mmHg
             (patients with type 2 diabetes: clinic systolic blood pressure≥150 mmHg and/or
             diastolic blood pressure≥95 mmHg) .

          5. . 24 hours ambulatory blood pressure (SBP/DBP)≥140 and/or 90 mmHg;

          6. . Estimated GFR (eGFR)≥45 ml/min / 1.73 m2.

        Exclusion Criteria:

          1. . Renal artery abnormalities include: either side renal arterial blood flow mechanics
             or anatomical obvious stenosis (≥50% ); Underwent renal artery balloon angioplasty or
             inserting a stent; Renal artery anatomy apparently is unusual to insert catheter;

          2. . Cardiovascular instability includes: myocardial infarction in six months, unstable
             angina or cerebrovascular disease; Thrombus or unstable plaques in the arteries with
             extensive atherosclerosis; Hemodynamic apparently change in patients with heart valve
             disease;

          3. . The patients with typeⅠdiabetes;

          4. . Other serious organic disease;

          5. . Participated in other clinical research.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>70 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>ChuanYu Gao, Dr.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Henan Institute of Cardiovascular Epidemiology</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Dayi Hu, Dr.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Henan Institute of Cardiovascular Epidemiology</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Lijie Zhu, master</last_name>
    <phone>+86 15225080141</phone>
    <email>zhulijie7788@163.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>ChuanYu Gao, Dr.</last_name>
    <phone>+86 13937165590</phone>
    <email>gaocy6802@163.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Zhengzhou university People's Hospital</name>
      <address>
        <city>Zhengzhou</city>
        <state>Henan</state>
        <zip>450000</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>ChuanYu Gao, Dr.</last_name>
      <phone>+86 13937165590</phone>
      <email>gaocy6802@163.com</email>
    </contact>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <verification_date>January 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>December 19, 2015</study_first_submitted>
  <study_first_submitted_qc>December 26, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">December 30, 2015</study_first_posted>
  <last_update_submitted>January 9, 2017</last_update_submitted>
  <last_update_submitted_qc>January 9, 2017</last_update_submitted_qc>
  <last_update_posted type="Estimate">January 10, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Henan Institute of Cardiovascular Epidemiology</investigator_affiliation>
    <investigator_full_name>Chuanyu Gao</investigator_full_name>
    <investigator_title>Principal Investigator</investigator_title>
  </responsible_party>
  <keyword>Renal sympathetic denervation;hypertension</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hypertension</mesh_term>
    <mesh_term>Adenoma</mesh_term>
    <mesh_term>Hyperaldosteronism</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

